DK173982B1 - Depolymeriserede heparinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat samt biologisk reagens med indhold heraf - Google Patents
Depolymeriserede heparinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat samt biologisk reagens med indhold heraf Download PDFInfo
- Publication number
- DK173982B1 DK173982B1 DK198802103A DK210388A DK173982B1 DK 173982 B1 DK173982 B1 DK 173982B1 DK 198802103 A DK198802103 A DK 198802103A DK 210388 A DK210388 A DK 210388A DK 173982 B1 DK173982 B1 DK 173982B1
- Authority
- DK
- Denmark
- Prior art keywords
- heparin
- fragments
- approx
- daltons
- molecular weight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8705457 | 1987-04-16 | ||
FR8705457A FR2614026B1 (fr) | 1987-04-16 | 1987-04-16 | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
Publications (3)
Publication Number | Publication Date |
---|---|
DK210388D0 DK210388D0 (da) | 1988-04-18 |
DK210388A DK210388A (da) | 1988-10-17 |
DK173982B1 true DK173982B1 (da) | 2002-03-25 |
Family
ID=9350219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198802103A DK173982B1 (da) | 1987-04-16 | 1988-04-18 | Depolymeriserede heparinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat samt biologisk reagens med indhold heraf |
Country Status (18)
Country | Link |
---|---|
US (1) | US4990502A (de) |
EP (1) | EP0287477B1 (de) |
JP (1) | JPS63278901A (de) |
KR (1) | KR880012644A (de) |
AR (1) | AR243205A1 (de) |
AT (1) | ATE113611T1 (de) |
AU (1) | AU601566B2 (de) |
CA (1) | CA1327968C (de) |
DE (1) | DE3851973T2 (de) |
DK (1) | DK173982B1 (de) |
FI (1) | FI88046C (de) |
FR (1) | FR2614026B1 (de) |
IE (1) | IE64884B1 (de) |
IL (1) | IL86091A0 (de) |
NO (1) | NO170940C (de) |
NZ (1) | NZ224275A (de) |
PT (1) | PT87261B (de) |
ZA (1) | ZA882662B (de) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1234826B (it) * | 1989-01-30 | 1992-05-29 | Alfa Wassermann Spa | Derivati eparinici e procedimento per la loro preparazione |
IT1237518B (it) * | 1989-11-24 | 1993-06-08 | Renato Conti | Eparine supersolfatate |
USRE38743E1 (en) | 1990-06-26 | 2005-06-14 | Aventis Pharma S.A. | Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events |
FR2663639B1 (fr) * | 1990-06-26 | 1994-03-18 | Rhone Poulenc Sante | Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation. |
FR2669932B1 (fr) * | 1990-12-03 | 1994-07-01 | Sanofi Sa | Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent. |
US5280016A (en) * | 1991-03-29 | 1994-01-18 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
MX9201801A (es) * | 1991-04-16 | 1992-10-30 | Seikagaku Kogyo Co Ltd | Oligosacarido que tiene afinidad para el factor de desarrollo del fibroplasto y procedimiento para producirlo. |
SE9101155D0 (sv) * | 1991-04-18 | 1991-04-18 | Kabi Pharmacia Ab | Novel heparin derivatives |
KR100235782B1 (ko) * | 1991-05-02 | 1999-12-15 | 파울리나 벤-아미 | 병리학적 과정의 예방 또는 치료를 위한 성분물 |
US6750207B1 (en) | 1992-05-01 | 2004-06-15 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
WO1994011006A1 (en) * | 1992-11-10 | 1994-05-26 | Yeda Research And Development Co. Ltd. | Compositions for the regulation of cytokine activity |
US5861382A (en) * | 1992-05-01 | 1999-01-19 | Yeda Research And Development Co. Ltd. | Methods for regulation of active TNF-α |
FR2691066B1 (fr) * | 1992-05-15 | 1995-06-09 | Sanofi Elf | Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies. |
US5696100A (en) * | 1992-12-22 | 1997-12-09 | Glycomed Incorporated | Method for controlling O-desulfation of heparin and compositions produced thereby |
US5650389A (en) * | 1993-03-01 | 1997-07-22 | University Of Alabama At Birmingham Research Foundation | Methods for the inhibition of complement activation |
FR2704226B1 (fr) * | 1993-04-22 | 1995-07-21 | Sanofi Elf | 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
IT1264709B1 (it) * | 1993-07-12 | 1996-10-04 | Italfarmaco Spa | Derivati eparinici ad attivita' antimetastatica |
US5583121A (en) * | 1994-01-12 | 1996-12-10 | Michigan State University | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
US6127347A (en) * | 1994-01-12 | 2000-10-03 | Univ Michigan | Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes |
CA2189038A1 (en) * | 1994-05-06 | 1995-11-09 | Kevin R. Holme | O-desulfated heparin derivatives, methods of making and uses thereof |
US5639469A (en) * | 1994-06-15 | 1997-06-17 | Minnesota Mining And Manufacturing Company | Transmucosal delivery system |
US6001820A (en) * | 1995-03-31 | 1999-12-14 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
DE69623840D1 (de) * | 1995-03-31 | 2002-10-31 | Hamilton Civic Hospitals Res | Zusammensetzung zur Hemmung der Thromboseentstehung |
US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
US5763427A (en) * | 1995-03-31 | 1998-06-09 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
WO1997016556A1 (en) | 1995-10-30 | 1997-05-09 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase i |
US6562781B1 (en) * | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
US6491965B1 (en) | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
FR2763848B1 (fr) | 1997-05-28 | 2000-01-28 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central |
CA2293595A1 (en) * | 1997-06-06 | 1998-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Modified low molecular weight heparin that inhibits clot associated coagulation factors |
AU1173599A (en) | 1997-11-20 | 1999-06-15 | Ikuo Yamashina | Low-molecular heparin modification and remedy for skin ulcer |
EP1059304B1 (de) * | 1998-02-26 | 2006-04-26 | Seikagaku Corporation | Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten |
US6028061A (en) * | 1998-06-18 | 2000-02-22 | Children's Medical Center Corp | Angiogenesis inhibitors and use thereof |
JP2003527822A (ja) * | 1998-08-27 | 2003-09-24 | マサチューセッツ インスティテュート オブ テクノロジー | ヘパリナーゼiおよびii由来の合理的に設計されたヘパリナーゼ |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
JP4633223B2 (ja) * | 1999-03-31 | 2011-02-16 | 生化学工業株式会社 | 血管内皮細胞増殖因子依存性血管内皮細胞増殖の抑制剤 |
WO2000065521A2 (en) * | 1999-04-23 | 2000-11-02 | Massachusetts Institute Of Technology | System and method for polymer notation |
JP2003504428A (ja) * | 1999-06-30 | 2003-02-04 | ハミルトン シビック ホスピタルズ リサーチ ディベロップメント インコーポレイテッド | クロット関連凝固因子を阻害するヘパリン組成物 |
IT1316986B1 (it) * | 2000-01-25 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica. |
US20080139503A1 (en) * | 2000-01-25 | 2008-06-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
US7781416B2 (en) * | 2000-01-25 | 2010-08-24 | Sigma-Tau Research Switzerland S.A. | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
CA2402160C (en) | 2000-03-08 | 2012-02-14 | Massachusetts Institute Of Technology | Heparinase iii and uses thereof |
JP4633233B2 (ja) * | 2000-06-29 | 2011-02-16 | 生化学工業株式会社 | クラミジア感染症処置剤 |
IL154771A0 (en) * | 2000-09-08 | 2003-10-31 | Hamilton Civic Hospitals Res | Antithrombotic compositions |
WO2002023190A2 (en) * | 2000-09-12 | 2002-03-21 | Massachusetts Institute Of Technology | Methods and products related to low molecular weight heparin |
AU2002224408B2 (en) * | 2000-10-18 | 2007-08-23 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
EP2343077B1 (de) * | 2001-09-12 | 2013-07-17 | SIGMA-TAU Research Switzerland S.A. | Derivate von total N-desulfatierten Glycosaminoglycanen als Inhibitoren von Heparanase, mit antiangiogener Wirkung und ohne antikoagulatorische Wirkung |
US7285536B2 (en) | 2001-12-05 | 2007-10-23 | Yeda Research And Development Co., Ltd. | Anti-cancer therapeutic compounds |
EP2284535A1 (de) * | 2002-03-11 | 2011-02-16 | Momenta Pharmaceuticals, Inc. | Heparine mit niedrigem Molekulargewicht |
EP1551852A4 (de) * | 2002-04-25 | 2007-03-21 | Momenta Pharmaceuticals Inc | Verfahren und produkte zur verabreichung an die schleimhaut |
ITMI20031679A1 (it) * | 2003-08-29 | 2005-02-28 | Opocrin Spa | Processo per la produzione di eparine a basso peso |
EP1582531A1 (de) | 2004-03-24 | 2005-10-05 | Aventis Pharma S.A. | Verfahren zur Oxydierung nicht-fraktionierten Heparins und die Detektion der Anwesenheit oder Abwesenheit von Glykoserin in Heparin und in von Heparin abgeleiteten Produkten |
WO2007019554A2 (en) * | 2005-08-08 | 2007-02-15 | Momenta Pharmaceuticals, Inc. | Polysaccharides for delivery of active agents |
EP1792621B1 (de) | 2005-11-30 | 2012-04-04 | Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" | Oral verabreichbare Heparinderivate |
US9139876B1 (en) | 2007-05-03 | 2015-09-22 | Momenta Pharmacueticals, Inc. | Method of analyzing a preparation of a low molecular weight heparin |
WO2009007224A1 (en) * | 2007-07-10 | 2009-01-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Low molecular weight heparin derivatives having neuroprotective activity |
ES2567079T3 (es) * | 2007-11-02 | 2016-04-19 | Momenta Pharmaceuticals, Inc. | Composiciones de polisacáridos que no son anticoagulantes |
US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
WO2009141821A1 (en) * | 2008-05-20 | 2009-11-26 | Crystal Clear Partnership | Separation of polysaccharides by charge density gradient |
CN102046781A (zh) | 2008-05-30 | 2011-05-04 | 动量制药公司 | 糖结构以及制造和使用此类结构的方法 |
CN102791742B (zh) * | 2010-01-19 | 2014-12-24 | 动量制药公司 | 评价肝素制剂 |
US9387256B2 (en) | 2010-04-16 | 2016-07-12 | Momenta Pharmaceuticals, Inc. | Tissue targeting |
US10017585B2 (en) | 2010-06-17 | 2018-07-10 | Momenta Pharmaceuticals, Inc. | Methods and compositions for promoting hair growth |
WO2012115952A1 (en) | 2011-02-21 | 2012-08-30 | Momenta Pharmaceuticals, Inc. | Evaluating heparin preparations |
EP2794665B1 (de) * | 2011-12-19 | 2017-11-22 | Dilafor AB | Nicht antikoagulative glykosaminoglykane mit sich wiederholender disaccharideinheit und ihre medizinische verwendung |
WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
SG11201406119WA (en) * | 2012-03-26 | 2014-11-27 | Dilafor Ab | Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
WO2014193818A1 (en) | 2013-05-28 | 2014-12-04 | Momenta Pharmaceuticals, Inc. | Pharmaceutical compositions |
GB2515315A (en) * | 2013-06-19 | 2014-12-24 | Dilafor Ab | New Processes |
CN108424474B (zh) * | 2017-02-15 | 2023-07-25 | 清华大学 | 去抗凝肝素衍生物及其用于炎症性肠病的治疗 |
BR112022000255A8 (pt) | 2019-07-09 | 2022-03-22 | Optimvia Llc | Métodos para sintetizar polissacarídeos anticoagulantes |
EP4182452A4 (de) | 2020-07-14 | 2024-07-31 | Optimvia Llc | Verfahren zur synthese von nicht-antikoagulierendem heparansulfat |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE620906A (de) * | ||||
FR2440376A1 (fr) * | 1978-11-06 | 1980-05-30 | Choay Sa | Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir |
CA1136620A (en) * | 1979-01-08 | 1982-11-30 | Ulf P.F. Lindahl | Heparin fragments having selective anticoagulation activity |
US4826827A (en) * | 1979-10-05 | 1989-05-02 | Choay S.A. | Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs |
CA1171375A (en) * | 1980-09-15 | 1984-07-24 | Ulf P.F. Lindahl | Oligosaccharides having selective anticoagulation activity |
US4801583A (en) * | 1982-01-15 | 1989-01-31 | Choay S.A. | Oligosaccharides and their biological applications |
US4533549A (en) * | 1983-01-04 | 1985-08-06 | Lasker Sigmund E | Antithrombotic agent |
IT1195497B (it) * | 1983-03-08 | 1988-10-19 | Opocrin Spa | Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina |
US4687765A (en) * | 1983-07-25 | 1987-08-18 | Choay S.A. | Method and composition for thrombolytic treatment |
FR2568774B2 (fr) * | 1984-05-30 | 1989-05-19 | Choay Sa | Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique |
FR2584606A1 (fr) * | 1985-07-12 | 1987-01-16 | Dropic | Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif |
US4788307A (en) * | 1986-04-30 | 1988-11-29 | Choay S.A. | Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity |
US4745106A (en) * | 1986-08-20 | 1988-05-17 | Griffin Charles C | Heparin derivatives having improved anti-Xa specificity |
-
1987
- 1987-04-16 FR FR8705457A patent/FR2614026B1/fr not_active Expired - Lifetime
-
1988
- 1988-04-15 US US07/181,969 patent/US4990502A/en not_active Expired - Lifetime
- 1988-04-15 JP JP63091891A patent/JPS63278901A/ja active Pending
- 1988-04-15 NZ NZ224275A patent/NZ224275A/xx unknown
- 1988-04-15 IL IL86091A patent/IL86091A0/xx unknown
- 1988-04-15 AT AT88400928T patent/ATE113611T1/de not_active IP Right Cessation
- 1988-04-15 NO NO881660A patent/NO170940C/no not_active IP Right Cessation
- 1988-04-15 CA CA000564296A patent/CA1327968C/fr not_active Expired - Lifetime
- 1988-04-15 ZA ZA882662A patent/ZA882662B/xx unknown
- 1988-04-15 PT PT87261A patent/PT87261B/pt not_active IP Right Cessation
- 1988-04-15 IE IE115088A patent/IE64884B1/en not_active IP Right Cessation
- 1988-04-15 AU AU14663/88A patent/AU601566B2/en not_active Expired
- 1988-04-15 DE DE3851973T patent/DE3851973T2/de not_active Expired - Lifetime
- 1988-04-15 EP EP88400928A patent/EP0287477B1/de not_active Expired - Lifetime
- 1988-04-15 AR AR88310583A patent/AR243205A1/es active
- 1988-04-15 FI FI881783A patent/FI88046C/fi not_active IP Right Cessation
- 1988-04-16 KR KR1019880004388A patent/KR880012644A/ko not_active Application Discontinuation
- 1988-04-18 DK DK198802103A patent/DK173982B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3851973D1 (de) | 1994-12-08 |
FI881783A (fi) | 1988-10-17 |
NO170940B (no) | 1992-09-21 |
EP0287477B1 (de) | 1994-11-02 |
NO881660D0 (no) | 1988-04-15 |
FI88046C (fi) | 1993-03-25 |
AU601566B2 (en) | 1990-09-13 |
PT87261B (pt) | 1992-08-31 |
DK210388D0 (da) | 1988-04-18 |
AR243205A1 (es) | 1993-07-30 |
NO881660L (no) | 1988-10-17 |
FI881783A0 (fi) | 1988-04-15 |
PT87261A (pt) | 1988-05-01 |
IL86091A0 (en) | 1988-09-30 |
DE3851973T2 (de) | 1995-06-08 |
IE64884B1 (en) | 1995-09-20 |
NZ224275A (en) | 1991-02-26 |
NO170940C (no) | 1992-12-30 |
US4990502A (en) | 1991-02-05 |
JPS63278901A (ja) | 1988-11-16 |
IE881150L (en) | 1988-10-16 |
ATE113611T1 (de) | 1994-11-15 |
CA1327968C (fr) | 1994-03-22 |
KR880012644A (ko) | 1988-11-28 |
EP0287477A3 (en) | 1989-07-26 |
ZA882662B (en) | 1988-10-14 |
FR2614026B1 (fr) | 1992-04-17 |
FI88046B (fi) | 1992-12-15 |
EP0287477A2 (de) | 1988-10-19 |
DK210388A (da) | 1988-10-17 |
AU1466388A (en) | 1988-10-20 |
FR2614026A1 (fr) | 1988-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK173982B1 (da) | Depolymeriserede heparinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat samt biologisk reagens med indhold heraf | |
US5280016A (en) | Non-anticoagulant heparin derivatives | |
US5013724A (en) | Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications | |
US5250519A (en) | Non-anticoagulant heparin derivatives | |
US5767269A (en) | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics | |
Casu et al. | Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate | |
HU210925B (en) | Process to prepare polisaccharide mixtures wita low moleculare weight and pharmaceutical compns. contg. them | |
ES2668273T3 (es) | Uso de derivados de heparina químicamente modificada en drepanocitosis | |
JP5351770B2 (ja) | ビオチンまたはビオチン誘導体との少なくとも1つの共有結合を含む低分子量ヘパリン、これらの作製方法およびそれらの使用。 | |
WO1998014481A9 (en) | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics | |
JPH09512822A (ja) | O−脱硫酸化ヘパリン誘導体とその製造法および使用 | |
PT99671B (pt) | Processo para a preparacao de heparosanos-n,o-sulfatados e de composicoes farmaceuticas que os contem | |
US5721357A (en) | Preparation of sulfated polysaccharides for treatment or prevention of thromboses | |
US20240041918A1 (en) | Oligosaccharide Compound for Inhibiting Intrinsic Coagulation Factor X-Enzyme Complex, and Preparation Method Therefor and Uses Thereof | |
DK174284B1 (da) | Biologisk aktive tetrasaccharider | |
US5849721A (en) | Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof | |
EP0408770B1 (de) | Sulfatiertes polysaccharid, dessen pharmazeutisch verträgliche salze, dessen herstellung und medikament, das dieses als wirksstoff enthält | |
CN108285498A (zh) | 一种抑制内源性凝血因子x酶复合物的寡糖化合物及其制备方法与用途 | |
NZ242431A (en) | Mixture of sulphated oligosaccharides derived from depolymerised heparin, and pharmaceutical compositions | |
RU2451515C2 (ru) | Композиции гепарина низкой молекулярной массы и их применение | |
Van Boeckel et al. | The action of serpins and heparin as leads in drug discovery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |